Gilead Sciences (GILD) 98.13 $GILD Final Glance:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 98.13 $GILD

Final Glance: Biotechnology companies
AP - 1 hr 2 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 98.13 (-2.56), AMGN: 159.85 (-4.45), CELG: 115.28 (-4.74)

Look for Shares of Gilead Sciences to Potentially Rebound after Yesterday's 2.54% Sell Off
Comtex SmarTrend(R) - 2 hrs 14 mins ago
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $98.07 to a high of $100.20. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $98.59 on volume of 13.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GILD: 98.13 (-2.56)

Genfit Is An Even Bet To Recover In The NASH Race
Clinically Sound Investor - at Seeking Alpha - 2 hrs 16 mins ago

RPTP: 10.87 (-1.17), GILD: 98.13 (-2.56), CNAT: 7.12 (-0.41), ICPT: 282.02 (-13.89)

AmerisourceBergen: A Great Growth Story
Bill Gunderson - Seeking Alpha - 2 hrs 16 mins ago
AmerisourceBergen (NYSE: ABC ) is a distributor of drugs and health supplies based in Chesterbrook, Pennsylvania. It runs 26 U.S. pharmaceutical distribution centers, 4 U.S. specialty distribution centers, and 2 Canadian distribution hubs, in order...
ABC: 113.67 (+0.18), JNJ: 100.60 (-0.95), WBA: 84.68 (-1.31), MCK: 226.20 (-2.94), MWIV: 190.00 (+0.10), GILD: 98.13 (-2.56), CAH: 90.27 (-0.53), ABBV: 58.54 (+0.30)

What to Look for This Earnings Season - Earnings Outlook
Sheraz Mian - Zacks Investment Research - Tue Mar 31, 2:27PM CDT
What to Look for This Earnings Season - Earnings Outlook
GILD: 98.13 (-2.56), BAC: 15.39 (-0.13), AAPL: 124.43 (-1.94)

What to Look for This Earnings Season - Earnings Trends
Sheraz Mian - Zacks Investment Research - Tue Mar 31, 2:27PM CDT
What to Look for This Earnings Season - Earnings Trends
GILD: 98.13 (-2.56), BAC: 15.39 (-0.13), AAPL: 124.43 (-1.94)

Midday Glance: Biotechnology companies
AP - Tue Mar 31, 1:48PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
GILD: 98.13 (-2.56), AMGN: 159.85 (-4.45), CELG: 115.28 (-4.74)

Gilead Versus Celgene: Value Play Versus Reinvestment Opportunity
Intrepid Investor - at Seeking Alpha - Tue Mar 31, 1:36PM CDT

GILD: 98.13 (-2.56), CELG: 115.28 (-4.74)

Post-UNH Deal, Spotlight on Pharmacy Benefit Stocks - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 31, 10:06AM CDT
Health insurers might start thinking about adding pharmacy benefit managers to their portfolio following the news that a unit of UnitedHealth Group (UNH) is taking over Catamaran Corporation (CTRX).
CTRX: 59.54 (-0.29), ESRX: 86.77 (+1.37), GILD: 98.13 (-2.56), UNH: 118.29 (-2.71), CVS: 103.21 (-0.62), RAD: 8.69 (-0.07)

Early Glance: Biotechnology companies
AP - Tue Mar 31, 9:29AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:
GILD: 98.13 (-2.56), AMGN: 159.85 (-4.45), CELG: 115.28 (-4.74)

Critical Alerts For Invensense, SolarCity, Gilead Sciences, Mylan and Foot Locker Released By InvestorsObserver
PR Newswire - Tue Mar 31, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for INVN, SCTY, GILD, MYL and FL.
GILD: 98.13 (-2.56), SCTY: 51.28 (+0.71), INVN: 15.21 (-0.31), MYL: 59.35 (-0.65), FL: 63.00 (-0.61)

'Fast Money' Recap: A Stock Rally With 'Window Dressing'
at The Street - Tue Mar 31, 4:00AM CDT
The trading panel discussed volatility, GoPro and biotech stocks.
TSLA: 188.77 (-1.80), GPRO: 43.41 (-0.17), SPY: 206.43 (-1.82), GILD: 98.13 (-2.56), C: 51.52 (-0.12), IBB: 343.43 (-7.89), AMGN: 159.85 (-4.45), IWM: 124.37 (-0.40), IYT: 156.62 (-0.84), INTC: 31.27 (-0.19), CELG: 115.28 (-4.74)

3 Triple-Digit Stocks With Upside Potential of At Least 40%
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 30, 6:00PM CDT
Source: Flickr user www.vpsi.org.  It's a common misconception among new investors, and one that even veterans occasionally make: assuming that a stock's price is the ultimate determinant of value. Of the more than 7,000 stocks currently listed...
GILD: 98.13 (-2.56), NXPI: 100.36 (-2.07), FSL: 40.76 (-0.72), AAPL: 124.43 (-1.94)


UnitedHealth bulks up for prescription drug cost battle
By TOM MURPHY - AP - Mon Mar 30, 4:32PM CDT
The nation's largest health insurer, UnitedHealth, will muscle up for its fight against rising prescription drug costs by spending more than $12 billion to buy pharmacy benefits manager Catamaran Corp.
JNJ: 100.60 (-0.95), ESRX: 86.77 (+1.37), CTRX: 59.54 (-0.29), GILD: 98.13 (-2.56), UNH: 118.29 (-2.71), CCT.TO: 75.40 (-0.48)

Gilead Sciences Inc. Faces An Uncertain Future After Patent Loss In India
Rami Alsamaraee - at Seeking Alpha - Mon Mar 30, 1:07PM CDT

GILD: 98.13 (-2.56)

Gilead Sciences (GILD) Crosses Pivot Point Support at $100.57
Comtex SmarTrend(R) - Mon Mar 30, 9:39AM CDT
Shares of Gilead Sciences (NASDAQ:GILD) have bearishly opened below the pivot of $101.33 today and have reached the first support level of $100.57. Investors may be interested in a cross of the next downside pivot targets of $100.13 and $98.93.
GILD: 98.13 (-2.56)

The Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers Squibb, Achillion Pharmaceuticals and Cambrex - Press Releases
Zacks Equity Research - Zacks Investment Research - Mon Mar 30, 8:30AM CDT
The Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers Squibb, Achillion Pharmaceuticals and Cambrex
CBM: 39.63 (+4.04), GILD: 98.13 (-2.56), ACHN: 9.86 (-0.38), BMY: 64.50 (-1.26)

The Best Dividend-Paying Healthcare Stocks
Todd Campbell, The Motley Fool - Motley Fool - Sun Mar 29, 12:07PM CDT
Dividend investing has been shown to outperform investing in companies that offer no payouts, but that doesn't mean all dividend payers are created equal. In health care, for example, patent expiration can mean some dividend-paying stocks pose...
GILD: 98.13 (-2.56), AZN: 68.43 (-1.51), UNH: 118.29 (-2.71), BMY: 64.50 (-1.26)

3 Best Dividend Stocks for 2015
Selena Maranjian, The Motley Fool - Motley Fool - Sun Mar 29, 11:12AM CDT
We're still in the first quarter of 2015, and many investors are on the lookout for strong dividend-paying stocks. It's smart to seek dividends, as they can significantly enhance your total returns, delivering growth even when the overall market is...
NOV: 49.99 (+0.15), GILD: 98.13 (-2.56), AAPL: 124.43 (-1.94)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Join Aktia's Exciting Investor Event This February

Updated Category News Views 106

Join Aktia's Exciting Investor Event This February Aktia Bank Plc is thrilled to invite investors, analysts, and media to its upcoming investor event. Set to take place on a date in February, this gathering offers a valuable opportunity for attendees to engage with the company’s leadership team and gain insights into Aktia’s strategic direction and future goals. Event...

Continue Reading
CVPR 2026: AI Frontier Expands with 16,000+ Papers

Updated Category News Views 11

When you hear that a tech conference pulled in over 16,000 paper submissions—even in the technical ivory tower that's AI—you've got to sit up and take notice. CVPR 2026, one of the biggest ticket events in the AI calendar, is running the show in Denver this year with gusto, posting a 24% spike in submissions over 2025. They've whittled it down to a tight 4,089 papers,...

Continue Reading
Earnings Week Highlights: Investors Eye Upcoming Reports

Updated Category News Views 275

Anticipated Earnings for the Week As we step into a week of earnings reports, numerous investors are gearing up to analyze the performance of key companies from various sectors including retail and technology. This week, we focus on significant upcoming reports, notably from discount retailers and cybersecurity firms, and major tech giants. Monday’s Earnings...

Continue Reading
CRO Services Market Growth Driven by Innovation and Demand

Updated Category News Views 168

CRO Services Market Growth Forecast The CRO Services Market is witnessing a remarkable transformation as pharmaceutical and biotechnology companies increasingly utilize the expertise of Contract Research Organizations (CROs). With a projected market value of USD 188.54 billion by the end of the forecast period, the industry is anticipated to grow at a compound annual...

Continue Reading
Desmond Bryant's Journey with Miami's Innovative Wellness Program

Updated Category News Views 316

Miami's Unique Wellness Experience for Executives At a Miami wellness startup, elite athletes and C-suite executives embark on a profound journey towards personal transformation. This innovative experience begins with a 90-minute guided hike through a picturesque nature preserve, allowing participants to disconnect from the daily grind and reconnect with themselves. This...

Continue Reading